1. Home
  2. MEI vs FATE Comparison

MEI vs FATE Comparison

Compare MEI & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MEI
  • FATE
  • Stock Information
  • Founded
  • MEI 1946
  • FATE 2007
  • Country
  • MEI United States
  • FATE United States
  • Employees
  • MEI N/A
  • FATE N/A
  • Industry
  • MEI Electrical Products
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MEI Technology
  • FATE Health Care
  • Exchange
  • MEI Nasdaq
  • FATE Nasdaq
  • Market Cap
  • MEI 402.1M
  • FATE 406.5M
  • IPO Year
  • MEI N/A
  • FATE 2013
  • Fundamental
  • Price
  • MEI $9.31
  • FATE $2.02
  • Analyst Decision
  • MEI Hold
  • FATE Buy
  • Analyst Count
  • MEI 3
  • FATE 11
  • Target Price
  • MEI $12.50
  • FATE $6.89
  • AVG Volume (30 Days)
  • MEI 354.2K
  • FATE 1.6M
  • Earning Date
  • MEI 12-05-2024
  • FATE 11-12-2024
  • Dividend Yield
  • MEI 6.02%
  • FATE N/A
  • EPS Growth
  • MEI N/A
  • FATE N/A
  • EPS
  • MEI N/A
  • FATE N/A
  • Revenue
  • MEI $1,083,300,000.00
  • FATE $13,447,000.00
  • Revenue This Year
  • MEI N/A
  • FATE N/A
  • Revenue Next Year
  • MEI $5.73
  • FATE N/A
  • P/E Ratio
  • MEI N/A
  • FATE N/A
  • Revenue Growth
  • MEI N/A
  • FATE N/A
  • 52 Week Low
  • MEI $8.54
  • FATE $1.96
  • 52 Week High
  • MEI $25.34
  • FATE $8.83
  • Technical
  • Relative Strength Index (RSI)
  • MEI 41.24
  • FATE 31.10
  • Support Level
  • MEI $8.70
  • FATE $2.33
  • Resistance Level
  • MEI $9.35
  • FATE $2.58
  • Average True Range (ATR)
  • MEI 0.40
  • FATE 0.25
  • MACD
  • MEI 0.04
  • FATE -0.04
  • Stochastic Oscillator
  • MEI 37.20
  • FATE 6.45

About MEI Methode Electronics Inc.

Methode Electronics Inc makes component and subsystem devices employing electrical, radio remote control, electronic, wireless, and sensing technologies. The firm is organized into various business segments: Automotive, Industrial, Interface, and Medical. The Automotive segment which generates maximum revenue, supplies electronic and electro-mechanical devices and related products to automobiles. The products manufactured in the automotive segment include overhead and center consoles, hidden and ergonomic switches, insert molded components, LED-based lighting, and sensors. Geographically, the company generates maximum revenue from North America and the rest from Europe, the Middle East & Africa (EMEA), and Asia.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: